176 related articles for article (PubMed ID: 29694893)
21. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
Diakos C; Xiao Y; Zheng S; Kager L; Dworzak M; Wiemels JL
PLoS One; 2014; 9(2):e87602. PubMed ID: 24503810
[TBL] [Abstract][Full Text] [Related]
22. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
23. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
Scheele JS; Kolanczyk M; Gantert M; Zemojtel T; Dorn A; Sykes DB; Möbest DC; Kamps MP; Räpple D
Leuk Lymphoma; 2009 May; 50(5):816-28. PubMed ID: 19399691
[TBL] [Abstract][Full Text] [Related]
24. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
Lee YL; Ito K; Pi WC; Lin IH; Chu CS; Malik S; Cheng IH; Chen WY; Roeder RG
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33542097
[TBL] [Abstract][Full Text] [Related]
25. Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia.
Wang X; Tan Y; Li Y; Li J; Jin W; Wang K
Front Med; 2016 Dec; 10(4):420-429. PubMed ID: 27888400
[TBL] [Abstract][Full Text] [Related]
26. Autophagy collaborates with ubiquitination to downregulate oncoprotein E2A/Pbx1 in B-cell acute lymphoblastic leukemia.
Yuan N; Song L; Lin W; Cao Y; Xu F; Liu S; Zhang A; Wang Z; Li X; Fang Y; Zhang H; Zhao W; Hu S; Wang J; Zhang S
Blood Cancer J; 2015 Jan; 5(1):e274. PubMed ID: 25615280
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.
McWhirter JR; Neuteboom ST; Wancewicz EV; Monia BP; Downing JR; Murre C
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11464-9. PubMed ID: 10500199
[TBL] [Abstract][Full Text] [Related]
28. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia.
Privitera E; Kamps MP; Hayashi Y; Inaba T; Shapiro LH; Raimondi SC; Behm F; Hendershot L; Carroll AJ; Baltimore D
Blood; 1992 Apr; 79(7):1781-8. PubMed ID: 1348433
[TBL] [Abstract][Full Text] [Related]
29. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
Casagrande G; te Kronnie G; Basso G
Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
[TBL] [Abstract][Full Text] [Related]
30. Folylpolyglutamate synthetase gene transcription is regulated by a multiprotein complex that binds the TEL-AML1 fusion in acute lymphoblastic leukemia.
Leclerc GJ; Sanderson C; Hunger S; Devidas M; Barredo JC
Leuk Res; 2010 Dec; 34(12):1601-9. PubMed ID: 20538338
[TBL] [Abstract][Full Text] [Related]
31. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma.
Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B
Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353
[TBL] [Abstract][Full Text] [Related]
32. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
Gerby B; Veiga DF; Krosl J; Nourreddine S; Ouellette J; Haman A; Lavoie G; Fares I; Tremblay M; Litalien V; Ottoni E; Kosic M; Geoffrion D; Ryan J; Maddox PS; Chagraoui J; Marinier A; Hébert J; Sauvageau G; Kwok BH; Roux PP; Hoang T
J Clin Invest; 2016 Dec; 126(12):4569-4584. PubMed ID: 27797342
[TBL] [Abstract][Full Text] [Related]
33. [E2A gene in t(1;19)-ALL].
Hayashi Y
Nihon Rinsho; 1992 Jun; 50(6):1369-73. PubMed ID: 1355570
[TBL] [Abstract][Full Text] [Related]
34. Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia.
Izraeli S; Kovar H; Gadner H; Lion T
Blood; 1992 Sep; 80(6):1413-7. PubMed ID: 1520867
[TBL] [Abstract][Full Text] [Related]
35. Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.
Woodcroft MW; Nanan K; Thompson P; Tyryshkin K; Smith SP; Slany RK; LeBrun DP
PLoS One; 2015; 10(6):e0130495. PubMed ID: 26098938
[TBL] [Abstract][Full Text] [Related]
36. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.
Chang CP; de Vivo I; Cleary ML
Mol Cell Biol; 1997 Jan; 17(1):81-8. PubMed ID: 8972188
[TBL] [Abstract][Full Text] [Related]
37. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
38. [Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia].
Gao C; Li ZG; Zhao W; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):569-73. PubMed ID: 18549631
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
Okuya M; Kurosawa H; Kikuchi J; Furukawa Y; Matsui H; Aki D; Matsunaga T; Inukai T; Goto H; Altura RA; Sugita K; Arisaka O; Look AT; Inaba T
J Biol Chem; 2010 Jan; 285(3):1850-60. PubMed ID: 19887369
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]